Conducted:
- 50 phase 1 clinical trials
- 220 late phase clinical trials
- 180 bioequivalence clinical trials
Passed a “full cycle”
- 30 clinical trials – from the first draft of the synopsis to the preparation of the final report for submission to the regulatory authorities.
More than
- 150 specialists
- 25 principal investigators involved in clinical trials
More than
600 documents have been developed for clinical trials, including
- 150 clinical trial protocols/programs
- 150 investigator brochures
- 150 informed consents
- 120 final reports of clinical trial results
- 12 research reports
- 45 scientific articles
Organizationally we have
- 3 hospitals with 70 beds
- 4 outpatient clinics
- 3 mass spectrometers in the Chemical Analysis Laboratory «QBioLab»
